Clusterin solubility and aggregation in Creutzfeldt-Jakob disease

被引:44
作者
Freixes, M
Puig, B
Rodríguez, A
Torrejón-Escribano, B
Blanco, R
Ferrer, I
机构
[1] Bellvitge Hosp, Inst Neuropathol, Serv Anat Patol, Lhospitalet De Llobregat 08907, Spain
[2] Univ Barcelona, Dept Biol Cellular Anat Patol, Unit Neuropatol, Lhospitalet De Llobregat 08907, Spain
[3] Serv Cientif Tecn, Unit Biol Bellvitge, Lhospitalet De Llobregat 08907, Spain
关键词
Creutzfeldt-Jakob disease; clusterin; prion protein;
D O I
10.1007/s00401-004-0891-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Prion protein (PrPC) is a glycolipid-anchored cell membrane syaloglycoprotein that localizes in presynaptic membranes. PrP has the property of aggregating into amyloid fibrils and being deposited in the brains in cases with transmissible encephalopathies (TSEs), when PrPC is converted into abnormal protease-resistant PrP (Prp(RES)). Clusterin is a heterodimeric glycoprotein, the expression of which is enhanced in astrocytes in association with punctate-type Prp(RES) deposits during TSE progression. In addition, clusterin co-localizes in Prp(RES) plaques in several human TSEs, including Creutzfeldt-Jakob disease (CJD). Clusterin is up-regulated in the cerebral cortex and cerebellum in CJD as revealed by DNA micro-array technology. Clusterin expression was examined in seven sporadic cases of CJD (codon 129 genotype, PrP type: 4 MM1, 1 MV1, 1 MV2, 1 VV2) and three age-matched controls by immunohistochemistry, Western blotting and solubility. In addition to small punctate clusterin deposition in the neuropil, single- and double-labeling immunohistochemistry disclosed clusterin localization in PrpRES plaques, which predominated in the cerebellum of cases MV1 MV2 and VV2. Moreover, clusterin in plaques, but not punctate clusterin deposits, was resistant to protease digestion, as revealed in tissue sections pre-incubated with proteinase K. Clusterin in CJD, but not clusterin in control brains, was partially resistant to protease digestion in Western blots of total brain homogenates immunostained with anti-clusterin antibodies, which were processed in parallel with Western blots to PrP, without and with pre-incubation with proteinase K. Protein aggregation was analyzed in brain homogenates subjected to several solvents. PrP was recovered in the deoxycholate fraction in control and CJD cases, but in the SDS fraction only in CJD, thus indicating differences in PrP solubility between CJD and controls. Clusterin was recovered in the cytosolic, deoxycholate and SDS fraction in both CJD and control cases, but only clusterin from CJD was recovered in the urea-soluble fraction and, especially, in the remaining pellet. These findings demonstrate the capacity of clusterin to form aggregates and interact with Prp(RES) aggregates. The implications of this property are not known, but it can be suggested that clusterin participates in PrP clustering and sequestration, thus modifying PrP toxicity in CJD.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 39 条
  • [1] Boggs LN, 1996, J NEUROCHEM, V67, P1324
  • [2] BUDKA H, 2003, NEURODEGENERATION MO, P287
  • [3] MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE
    BUELER, H
    AGUZZI, A
    SAILER, A
    GREINER, RA
    AUTENRIED, P
    AGUET, M
    WEISSMANN, C
    [J]. CELL, 1993, 73 (07) : 1339 - 1347
  • [4] APOLIPOPROTEIN-E AND APOLIPOPROTEIN-J IMMUNOREACTIVITY IN GERSTMANN-STRAUSSLER-SCHEINKER-DISEASE
    BUGIANI, O
    GIACCONE, G
    FRIGERIO, L
    FARLOW, MR
    GHETTI, B
    TAGLIAVINI, F
    [J]. NEUROBIOLOGY OF AGING, 1994, 15 : S156 - S157
  • [5] Clusterin (SGP-2) induction in rat astroglial cells exposed to prion protein fragment 106-126
    Chiesa, R
    Angeretti, N
    Lucca, E
    Salmona, M
    Tagliavini, F
    Bugiani, O
    Forloni, G
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (03) : 589 - 597
  • [6] ChoiMiura NH, 1996, NEUROBIOL AGING, V17, P717
  • [7] SP-40,40 IS A CONSTITUENT OF ALZHEIMERS AMYLOID
    CHOIMIURA, NH
    IHARA, Y
    FUKUCHI, K
    TAKEDA, M
    NAKANO, Y
    TOBE, T
    TOMITA, M
    [J]. ACTA NEUROPATHOLOGICA, 1992, 83 (03) : 260 - 264
  • [8] Prion diseases of humans and animals: Their causes and molecular basis
    Collinge, J
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 519 - 550
  • [9] DEARMOND SJ, 2003, GREENFIELDS NEUROPAT, V2, P273
  • [10] Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease
    DeMattos, RB
    O'dell, MA
    Parsadanian, M
    Taylor, JW
    Harmony, JAK
    Bales, KR
    Paul, SM
    Aronow, BJ
    Holtzman, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10843 - 10848